Print this page    •   Back to Web version of article

Mark S. King
My Fabulous Disease


AHF Reinstates Advocacy Funding and They Totally Mean It This Time
April 21, 2015

AIDS Healthcare Foundation (AHF) has quietly reinstated funding to a Louisiana AIDS advocacy event, two weeks after pulling their support because one of its organizers is involved in a whistleblower lawsuit against AHF. And they really mean it this time -- and would prefer that we believe the withdrawal of support never happened.

Read more …


Did AIDS Healthcare Foundation Just Retaliate Against Whistleblower?
April 13, 2015

The AIDS Healthcare Foundation scandal has taken a downright creepy turn.

Only one day after a stunning whistleblower lawsuit against AIDS Healthcare Foundation (AHF) was made public, the embattled organization withdrew funding from an upcoming HIV advocacy event because one of the plaintiffs is involved in its planning, according to records obtained by My Fabulous Disease.

Read more …


The Angry Fallout From the AIDS Healthcare Foundation Scandal
April 9, 2015

Michael Weinstein, the polarizing and famously litigious head of AIDS Healthcare Foundation (AHF) just got a taste of his own medicine when a stunning Whistleblower lawsuit against AHF filed last year was unsealed and made public.

Read more …


The First Man Cured of HIV to Join the HIV Cruise Retreat
February 23, 2015

The annual HIV Cruise Retreat, commonly referred to as "The Poz Cruise," will set sail this November 8-15 aboard the Ruby Princess, departing Los Angeles and cruising the Mexican Riviera cities of Mazatlan, Puerto Vallarta and Cabo San Lucas.

Read more …


Our Transgender Teachable Moment
February 3, 2015

The lobby of the Melbourne convention center at the international AIDS conference last July was packed with scientists, community educators, and activists. I was busy wrangling interviews for my daily video blogs.

Across the room I spotted JoAnne Keatley and Laxmi Narayan Tripathi, two of the most visible transgender women in the world and experts on transgender issues. I scurried up to them for a sound bite on their thoughts about the conference.

Read more …


My Gonorrhea Nostalgia
January 13, 2015

The first time I contracted gonorrhea, which in my day was affectionately called The Clap, I was 20 years old and had just moved to West Hollywood, California. It was 1981, disco was still thumping in the bars, and the bath houses were packed. My dance card was filled.

Read more …


The Disguised Blessings of HIV-Positive Poet Mary Bowman
January 13, 2015

When Mary E. Bowman stepped to the stage five years ago at SpitDat, an open mic night in Washington, D.C., she was 20 years old and terrified. She was about to perform "Dandelions," her first poem to reveal a secret that her own family had long kept quiet: that Mary had lived with HIV since birth, the result of a mother addicted to drugs who died when Mary was only three.

Read more …


15 HIV Advocates to Watch in 2015
January 6, 2015

They come from different cultures and regions of the world, but these fifteen HIV activists all share one important trait: a fierce devotion to HIV issues and a commitment to leave their mark on 2015.

Read more …


AIDS 2014 Video Blog: A Farewell, and Final Thoughts on Melbourne
August 4, 2014

By now the more scientific highlights from the 20th International AIDS Conference (AIDS 2014) in Melbourne has been digested and shared through your networks. There's always something unexpected -- and sometimes even encouraging, such as the new iPrEx study results showing, again, the efficacy of Truvada as pre-exposure prophylaxis (PrEP). The evidence mounts.

Read more …


AIDS 2014 Video Blog #5: Activist Theater, Condom Tryouts and a Mystery Man Revealed
July 25, 2014

This week, Gilead was targeted by hepatitis C treatment activists over the stunning price of its new hepatitis C drug, sofosbuvir (Sovaldi): US$1,000 per pill for each day of a 12-week regimen. Because the medication is both more effective and offers a shorter treatment period than previous therapies, activists see the drug as key to ending the hepatitis C scourge as we know it -- but warn that the price could keep that from happening. They took action here at the conference, and one of those events is in this video.

Read more …

 1  |  2  |  3  |  …  |  11  |  Next > 


You can find this article online by typing this address into your Web browser:
http://www.thebody.com/content/art48955.html

General Disclaimer: TheBody.com is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through TheBody.com should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.